• Profile
Close

Risk factors associated with altered circulating microRNA-125b and their influences on uremic vascular calcification among patients with end-stage renal disease

Journal of the American Heart Association Jan 21, 2019

Chao CT, et al. - Researchers investigated risk factors associated with low serum microRNA-125b (miR-125b) levels as well as the impact of miR-125b on vascular calcification (VC) risk in 223 patients on chronic dialysis for ≥3 months (mean age, 67.3 years; mean years of dialysis, 5.2), given that miR-125b has been shown to regulate VC. Multivariate regression analyses were performed. High serum miR-125b levels were detected in 54 (24.2%) patients. They quantified serum miR-125b and chronic kidney disease–mineral bone disorder effectors, including intact parathyroid hormone, 25-OH-D, fibroblast growth factor-23, osteoprotegerin, and fetuin-A. They found linear associations of osteoprotegerin (P=0.013), fibroblast growth factor-23 (P=0.006), and fetuin-A (P=0.036) with serum miR-125b levels. Among patients receiving chronic dialysis, an increased accuracy of VC risk estimation was offered by serum osteoprotegerin levels ≥400 pg/mL and serum miR-125b levels together.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay